10-Q

0001420565falseQ3--12-310001420565alrn:UnderwritingAgreementMemberus-gaap:CommonStockMember2024-05-3100014205652024-07-012024-09-300001420565alrn:OfferingWarrantSharesMemberalrn:UnderwritingAgreementMember2024-05-010001420565us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001420565us-gaap:RetainedEarningsMember2023-12-310001420565us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001420565alrn:HarvardAndDanafarberAgreementMemberus-gaap:LicenseAndMaintenanceMember2023-01-012023-09-300001420565us-gaap:CommonStockMember2024-03-050001420565alrn:UnderwritingAgreementMember2024-05-010001420565alrn:SeriesXNonVotingConvertiblePreferredStockMember2024-03-052024-03-050001420565alrn:SeriesXPreferredStockMember2024-01-012024-09-300001420565us-gaap:RetainedEarningsMember2022-12-310001420565us-gaap:RetainedEarningsMember2023-01-012023-03-3100014205652024-01-012024-03-3100014205652023-01-012023-09-3000014205652022-12-310001420565us-gaap:RetainedEarningsMember2024-01-012024-03-3100014205652023-07-012023-09-300001420565alrn:TwoThousandSeventeenEmployeeStockPurchasePlanMember2024-09-300001420565us-gaap:CommonStockMember2024-06-300001420565us-gaap:GeneralAndAdministrativeExpenseMember2023-07-012023-09-300001420565alrn:BiosEntitiesMember2024-09-300001420565us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001420565alrn:TwoThousandTwentyOneStockIncentivePlanMember2024-01-012024-09-300001420565alrn:BiosEntitiesMemberalrn:SeriesXPreferredStockMember2024-05-082024-05-080001420565us-gaap:WarrantMember2024-09-300001420565us-gaap:AdditionalPaidInCapitalMember2024-03-310001420565alrn:PurchaseAgreementMemberalrn:LungAcquisitionMemberalrn:SeriesXNonVotingConvertiblePreferredStockMember2023-10-312023-10-310001420565alrn:LungAcquisitionMemberalrn:CommonStockAndSeriesXPreferredStockMember2023-10-310001420565us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001420565alrn:SeriesXNonVotingConvertiblePreferredStockMember2024-06-300001420565us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBillSecuritiesMember2024-09-300001420565us-gaap:CommonStockMember2024-07-012024-09-300001420565alrn:SeriesXNonVotingConvertiblePreferredStockMember2024-04-012024-06-300001420565alrn:LungAcquisitionMemberalrn:SeriesXPreferredStockMember2023-10-310001420565us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001420565alrn:TwoThousandThirteenStockIncentivePlanMemberus-gaap:EmployeeStockOptionMemberalrn:LungTherapeuticsIncMember2024-01-012024-09-300001420565us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-09-3000014205652023-09-300001420565us-gaap:PreferredStockMember2024-01-012024-09-300001420565alrn:SeriesXNonVotingConvertiblePreferredStockMemberus-gaap:CommonStockMember2024-04-012024-06-3000014205652023-01-012023-03-310001420565alrn:SeriesXNonVotingConvertiblePreferredStockMember2024-03-310001420565us-gaap:WarrantMembersrt:MinimumMember2024-09-300001420565alrn:WholeShareMemberus-gaap:CommonStockMemberalrn:LungAcquisitionMember2023-10-312023-10-310001420565us-gaap:RetainedEarningsMember2024-07-012024-09-300001420565us-gaap:AdditionalPaidInCapitalMember2023-03-310001420565us-gaap:RetainedEarningsMember2023-07-012023-09-300001420565alrn:UniversityOfTexasHealthScienceCenterAtTylerAgreementMemberus-gaap:CommonStockMember2015-02-062015-02-06

SEC Form 10-Q filed by Aileron Therapeutics Inc.